Bluemoor Health reports quarterly revenue above the internal plan
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
Bluemoor Health
Healthcare · Medical Devices
Updated UTC
US$ 146,21
+1,91+1,32%
After hoursUS$ 145,56-0,44%
| Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 12,63 mld. | 14,13 mld. | 15,19 mld. | 15,96 mld. | 17,26 mld. |
| Gross profit | 7,23 mld. | 8,43 mld. | 8,68 mld. | 9,28 mld. | 10,31 mld. |
| Operating income | 2,62 mld. | 3,12 mld. | 3,2 mld. | 2,99 mld. | 3,14 mld. |
| Net income | 1,87 mld. | 1,82 mld. | 2,38 mld. | 2,03 mld. | 2,49 mld. |
Develops remote-monitoring hardware and clinical software for chronic-care providers.
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
The company approved a multi-year capital program intended to shorten lead times for its largest customers.
Market Wire
A sell-side desk kept a neutral rating while noting that near-term estimates already reflect steady execution.
Sector Desk
The board named an internal candidate with prior treasury and investor-relations experience to the role.
Market Wire
The authorization covers a modest slice of the float and will be funded from operating cash flow.
Market Wire